Multiple basal cell carcinoma and internal malignant tumors.

Area of Science:

• Dermatology
• Oncology
• Toxicology

Background:

• Multiple basal cell carcinoma (MBCC) is a common skin cancer.
• The association between MBCC and internal malignant neoplasms (IMNs) requires further clarification.
• Arsenic exposure is a known risk factor for various cancers.

Purpose of the Study:

• To investigate the relationship between multiple basal cell carcinoma and internal malignant neoplasms.
• To explore the potential impact of arsenic intake history on the occurrence of IMNs in MBCC patients.

Main Methods:

• Retrospective study of 196 patients diagnosed with multiple basal cell carcinoma.
• Analysis of observed versus expected frequencies of internal malignant neoplasms.
• Stratified analysis based on patient history of arsenic intake, examining gender differences.

Main Results:

• No statistically significant deviation was found between observed and expected cases of IMNs in the overall MBCC cohort.
• A notably higher incidence of internal tumors was observed in women with a history of arsenic intake, but not in men.
• The study sample size was insufficient to definitively establish a causal link between arsenic treatment and increased IMN incidence.

Conclusions:

• The presence of multiple basal cell carcinoma alone does not appear to significantly increase the risk of internal malignant neoplasms.
• Arsenic exposure may be associated with a higher risk of internal tumors, particularly in women, suggesting a need for more extensive research.
• Further comprehensive studies are recommended to validate the potential oncogenic effects of arsenic in humans.